A COMPARATIVE-STUDY OF INTRAVENOUS ACCELERATED STREPTOKINASE DOSE REGIMEN WITH CONVENTIONAL-DOSE REGIMEN FOR CORONARY THROMBOLYSIS

Citation
Cb. Xu et al., A COMPARATIVE-STUDY OF INTRAVENOUS ACCELERATED STREPTOKINASE DOSE REGIMEN WITH CONVENTIONAL-DOSE REGIMEN FOR CORONARY THROMBOLYSIS, Chinese medical journal, 110(1), 1997, pp. 59-61
Citations number
5
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
03666999
Volume
110
Issue
1
Year of publication
1997
Pages
59 - 61
Database
ISI
SICI code
0366-6999(1997)110:1<59:ACOIAS>2.0.ZU;2-S
Abstract
Recently, it has been reported that accelerated plasminogen activator dose regimens for coronary thrombolysis improves reperfusion rate.(1) Streptokinase (SK) has been widely used in Northern American and Europ ean countries to treat acute myocardial infarction (AMI).(2-4) The con ventional thrombolytic regimen was intravenous SK of 1.5 million units within 60 min. However, accelerated SK dose regimen for AMI has not b een reported. The aim of this study was to evaluate the patency rate a nd safety of the accelerated SK dose regimen for coronary thrombolysis compared with the conventional one.